BACKGROUND: In 2007, Swaziland initiated a hub-and-spoke model for decentralizing antiretroviral therapy (ART) access. Decentralization was facilitated through (1) down-referral of stable ART patients from overburdened central facilities (hubs) to primary health care clinics (spokes) and (2) ART initiation at spokes (spoke initiation). METHODS: We conducted a nationally representative retrospective cohort study among adult ART enrollees during 2004-2010 to assess the effect of down-referral and spoke-initiation on rates of loss to follow-up (LTFU), death, and attrition (death or LTFU). Sixteen of 31 hubs were randomly selected using probability-proportional-to-size sampling. Seven selected facilities had initiated the hub-and-spoke model by study start. At these facilities, 1149 of 24,782 hub-initiated and maintained and 878 of 7722 down-referred or spoke-initiated patient records were randomly selected and analyzed. At the 9 hub-only facilities, 483 of 6638 records were randomly selected and analyzed. Multivariable proportional hazards regression was used to assess effect of down-referral (a time-varying covariate) and spoke-initiation on outcomes. RESULTS: At ART initiation, median age was 35, 65% were female, and median CD4 count was 147 cells per microliter. Controlling for known confounders, down-referral was strongly protective against LTFU [adjusted hazard ratio (AHR) 0.38; 95% confidence interval (CI): 0.29 to 0.50] and attrition (AHR = 0.50; 95% CI: 0.34 to 0.76) but not mortality. Compared with hub-initiated and maintained patients, spoke-initiated patients had lower LTFU (AHR 0.59; 95% CI: 0.45 to 0.77) and attrition rates (AHR 0.60; 95% CI: 0.47 to 0.77), but not mortality. CONCLUSIONS: Down-referral and spoke-initiation within a hub-and-spoke ART decentralization model were protective against LTFU and overall attrition and could facilitate future ART program expansion.
BACKGROUND: In 2007, Swaziland initiated a hub-and-spoke model for decentralizing antiretroviral therapy (ART) access. Decentralization was facilitated through (1) down-referral of stable ART patients from overburdened central facilities (hubs) to primary health care clinics (spokes) and (2) ART initiation at spokes (spoke initiation). METHODS: We conducted a nationally representative retrospective cohort study among adult ART enrollees during 2004-2010 to assess the effect of down-referral and spoke-initiation on rates of loss to follow-up (LTFU), death, and attrition (death or LTFU). Sixteen of 31 hubs were randomly selected using probability-proportional-to-size sampling. Seven selected facilities had initiated the hub-and-spoke model by study start. At these facilities, 1149 of 24,782 hub-initiated and maintained and 878 of 7722 down-referred or spoke-initiated patient records were randomly selected and analyzed. At the 9 hub-only facilities, 483 of 6638 records were randomly selected and analyzed. Multivariable proportional hazards regression was used to assess effect of down-referral (a time-varying covariate) and spoke-initiation on outcomes. RESULTS: At ART initiation, median age was 35, 65% were female, and median CD4 count was 147 cells per microliter. Controlling for known confounders, down-referral was strongly protective against LTFU [adjusted hazard ratio (AHR) 0.38; 95% confidence interval (CI): 0.29 to 0.50] and attrition (AHR = 0.50; 95% CI: 0.34 to 0.76) but not mortality. Compared with hub-initiated and maintained patients, spoke-initiated patients had lower LTFU (AHR 0.59; 95% CI: 0.45 to 0.77) and attrition rates (AHR 0.60; 95% CI: 0.47 to 0.77), but not mortality. CONCLUSIONS: Down-referral and spoke-initiation within a hub-and-spoke ART decentralization model were protective against LTFU and overall attrition and could facilitate future ART program expansion.
Authors: Margaret L McNairy; Averie B Gachuhi; Matthew R Lamb; Harriet Nuwagaba-Biribonwoha; Sean Burke; Peter Ehrenkranz; Sikhathele Mazibuko; Ruben Sahabo; Neena M Philip; Velephi Okello; Wafaa M El-Sadr Journal: Implement Sci Date: 2015-07-19 Impact factor: 7.327
Authors: Grace O Kolawole; Hannah N Gilbert; Nancin Y Dadem; Becky L Genberg; Patricia A Agaba; Prosper Okonkwo; Oche O Agbaji; Norma C Ware Journal: AIDS Res Treat Date: 2017-02-26
Authors: Patricia A Agaba; Becky L Genberg; Atiene S Sagay; Oche O Agbaji; Seema T Meloni; Nancin Y Dadem; Grace O Kolawole; Prosper Okonkwo; Phyllis J Kanki; Norma C Ware Journal: J AIDS Clin Res Date: 2018-02-13
Authors: Kristen A Stafford; Solomon F Odafe; Julia Lo; Ramat Ibrahim; Akipu Ehoche; Mercy Niyang; Gambo G Aliyu; Bola Gobir; Dennis Onotu; Ademola Oladipo; Ibrahim Dalhatu; Andrew T Boyd; Otse Ogorry; Lawal Ismail; Manhattan Charurat; Mahesh Swaminathan Journal: PLoS One Date: 2019-07-10 Impact factor: 3.240
Authors: Ingrid V Bassett; Mingshu Huang; Christie Cloete; Sue Candy; Janet Giddy; Simone C Frank; Kenneth A Freedberg; Elena Losina; Rochelle P Walensky; Robert A Parker Journal: J Int AIDS Soc Date: 2019-06 Impact factor: 5.396
Authors: Bernhard Kerschberger; Michael Schomaker; Kiran Jobanputra; Serge M Kabore; Roger Teck; Edwin Mabhena; Simangele Mthethwa-Hleza; Barbara Rusch; Iza Ciglenecki; Andrew Boulle Journal: J Int AIDS Soc Date: 2020-03 Impact factor: 5.396
Authors: Bernhard Kerschberger; Michael Schomaker; Iza Ciglenecki; Lorraine Pasipamire; Edwin Mabhena; Alex Telnov; Barbara Rusch; Nomthandazo Lukhele; Roger Teck; Andrew Boulle Journal: Trop Med Int Health Date: 2019-04-01 Impact factor: 2.622
Authors: Margaret L McNairy; Matthew R Lamb; Averie B Gachuhi; Harriet Nuwagaba-Biribonwoha; Sean Burke; Sikhathele Mazibuko; Velephi Okello; Peter Ehrenkranz; Ruben Sahabo; Wafaa M El-Sadr Journal: PLoS Med Date: 2017-11-07 Impact factor: 11.069
Authors: Elizabeth R Stevens; Lingfeng Li; Kimberly A Nucifora; Qinlian Zhou; Margaret L McNairy; Averie Gachuhi; Matthew R Lamb; Harriet Nuwagaba-Biribonwoha; Ruben Sahabo; Velephi Okello; Wafaa M El-Sadr; R Scott Braithwaite Journal: PLoS One Date: 2018-09-17 Impact factor: 3.240